Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction
- PMID: 27398406
- PMCID: PMC4936401
- DOI: 10.17756/jrds.2015-016
Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction
Abstract
Recently there has been debate concerning the role of brain dopamine in reward and addiction. David Nutt and associates eloquently proposed that dopamine (DA) may be central to psycho stimulant dependence and some what important for alcohol, but not important for opiates, nicotine or even cannabis. Others have also argued that surfeit theories can explain for example cocaine seeking behavior as well as non-substance-related addictive behaviors. It seems prudent to distinguish between what constitutes "surfeit" compared to" deficit" in terms of short-term (acute) and long-term (chronic) brain reward circuitry responsivity. In an attempt to resolve controversy regarding the contributions of mesolimbic DA systems to reward, we review the three main competing explanatory categories: "liking", "learning", and "wanting". They are (a) the hedonic impact -liking reward, (b) the ability to predict rewarding effects-learning and (c) the incentive salience of reward-related stimuli -wanting. In terms of acute effects, most of the evidence seems to favor the "surfeit theory". Due to preferential dopamine release at mesolimbic-VTA-caudate-accumbens loci most drugs of abuse and Reward Deficiency Syndrome (RDS) behaviors have been linked to heightened feelings of well-being and hyperdopaminergic states.The "dopamine hypotheses" originally thought to be simple, is now believed to be quite complex and involves encoding the set point of hedonic tone, encoding attention, reward expectancy, and incentive motivation. Importantly, Willuhn et al. shows that in a self-administration paradigm, (chronic) excessive use of cocaine is caused by decreased phasic dopamine signaling in the striatum. In terms of chronic addictions, others have shown a blunted responsivity at brain reward sites with food, nicotine, and even gambling behavior. Finally, we are cognizant of the differences in dopaminergic function as addiction progresses and argue that relapse may be tied to dopamine deficiency. Vulnerability to addiction and relapse may be the result of the cumulative effects of dopaminergic and other neurotransmitter genetic variants and elevated stress levels. We therefore propose that dopamine homeostasis may be a preferred goal to combat relapse.
Keywords: Dopamine receptors; Incentive salience; Learning; Liking and wanting; Neurogenetics; Reward deficiency syndrome; Surfeit.
Figures
Similar articles
-
"Liking" and "wanting" linked to Reward Deficiency Syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry.Curr Pharm Des. 2012;18(1):113-8. doi: 10.2174/138161212798919110. Curr Pharm Des. 2012. PMID: 22236117 Free PMC article.
-
The debate over dopamine's role in reward: the case for incentive salience.Psychopharmacology (Berl). 2007 Apr;191(3):391-431. doi: 10.1007/s00213-006-0578-x. Epub 2006 Oct 27. Psychopharmacology (Berl). 2007. PMID: 17072591 Review.
-
Addiction and brain reward and antireward pathways.Adv Psychosom Med. 2011;30:22-60. doi: 10.1159/000324065. Epub 2011 Apr 19. Adv Psychosom Med. 2011. PMID: 21508625 Free PMC article. Review.
-
Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary.Theor Biol Med Model. 2008 Nov 12;5:24. doi: 10.1186/1742-4682-5-24. Theor Biol Med Model. 2008. PMID: 19014506 Free PMC article. Review.
-
Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS).J Neurol Sci. 2020 Apr 15;411:116733. doi: 10.1016/j.jns.2020.116733. Epub 2020 Feb 14. J Neurol Sci. 2020. PMID: 32088516 Review.
Cited by
-
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids.J Pers Med. 2022 Dec 6;12(12):2015. doi: 10.3390/jpm12122015. J Pers Med. 2022. PMID: 36556236 Free PMC article. Review.
-
The long-term outcome of patients with heroin use disorder/dual disorder (chronic psychosis) after admission to enhanced methadone maintenance.Ann Gen Psychiatry. 2018 Apr 18;17:14. doi: 10.1186/s12991-018-0185-3. eCollection 2018. Ann Gen Psychiatry. 2018. PMID: 29692860 Free PMC article.
-
Editorial: Stress and addictive disorders.Front Psychiatry. 2023 Oct 31;14:1307732. doi: 10.3389/fpsyt.2023.1307732. eCollection 2023. Front Psychiatry. 2023. PMID: 38025442 Free PMC article. No abstract available.
-
Neuropharmacological and Neurogenetic Correlates of Opioid Use Disorder (OUD) As a Function of Ethnicity: Relevance to Precision Addiction Medicine.Curr Neuropharmacol. 2020;18(7):578-595. doi: 10.2174/1570159X17666191118125702. Curr Neuropharmacol. 2020. PMID: 31744450 Free PMC article. Review.
-
Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail.Front Pharmacol. 2022 Apr 7;13:859563. doi: 10.3389/fphar.2022.859563. eCollection 2022. Front Pharmacol. 2022. PMID: 35462918 Free PMC article. Review.
References
-
- Nutt DJ, Lingford-Hughes A, Erritzoe D, Stokes PR. The dopamine theory of addiction: 40 years of highs and lows. Nat Rev Neurosci. 2015;16(5):305–312. doi: 10.1038/nrn3939. - PubMed
-
- Bowirrat A, Oscar-Berman M. Relationship between dopaminergic neurotransmission, alcoholism, and Reward Deficiency syndrome. Am J Med Genet B Neuropsychiatr Genet. 2005;132B(1):29–37. doi: 10.1002/ajmg.b.30080. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources